In this Dec. 25, 2020 photo released by Xinhua News Agency, packages of COVID-19 vaccine products are seen at a production plant of the Beijing Biological Products Institute Co., Ltd, a unit of state-owned Sinopharm in Beijing. (Zhang Yuwei/Xinhua via AP, File)